Visionary Asset Management’s AbbVie ABBV Stock Holding History

Visionary Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2,658	Closed	-$257K	–	269
2017 Q4	$257K	Sell	2,658 -39,764	-94%	-$3.75M	0.07%	192
2017 Q3	$3.77M	Sell	42,422 -3,307	-7%	-$252K	1.1%	10
2017 Q2	$3.32M	Sell	45,729 -4,963	-10%	-$334K	0.97%	22
2017 Q1	$3.3M	Buy	50,692 +1,839	+4%	+$116K	1.02%	39
2016 Q4	$3.06M	Buy	48,853 +2,950	+6%	+$180K	1%	52
2016 Q3	$2.9M	Buy	45,903 +1,035	+2%	+$67K	1%	43
2016 Q2	$2.78M	Buy	44,868 +1,563	+4%	+$95.2K	0.99%	24
2016 Q1	$2.47M	Buy	+43,305	New	+$2.41M	0.88%	52
2015 Q1	–	Sell	-152	Closed	-$10K	–	110
2014 Q4	$10K	Sell	152 -49,224	-100%	-$3.1M	﹤0.01%	132
2014 Q3	$2.85M	Buy	49,376 +10,503	+27%	+$583K	0.79%	21
2014 Q2	$2.19M	Buy	38,873 +11,578	+42%	+$607K	0.51%	21
2014 Q1	$1.4M	Buy	27,295 +7,691	+39%	+$389K	0.33%	53
2013 Q4	$1.03M	Buy	+19,604	New	+$964K	0.28%	38

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Visionary Asset Management's ABBV Position: Q1 2018 in Review

Visionary Asset Management sold out of AbbVie (ABBV) in Q1 2018, closing a stake of 2,658 shares — an estimated $257K sold.

Visionary Asset Management first reported a position in ABBV in Q4 2013 and held it in 13 quarters. The position peaked at $3.77M in Q3 2017. 2,016 funds tracked by Wall St. Rank hold ABBV as of Q1 2018.

Visionary Asset Management reported no remaining AbbVie position as of Q1 2018 after selling out during the quarter.
Visionary Asset Management sold 2,658 AbbVie shares in Q1 2018, an estimated $257K.
Visionary Asset Management first reported a position in AbbVie in Q4 2013 and held it in 13 quarters.
Visionary Asset Management's AbbVie position peaked at $3.77M in Q3 2017.
2,016 funds tracked by Wall St. Rank held AbbVie as of Q1 2018.

Based on Visionary Asset Management's 13F filing for Q1 2018, filed 13 Apr 2018.